INHIBIKASE THERAPEUTICS, INC.Equity Distribution Agreement • May 17th, 2022 • New York
Contract Type FiledMay 17th, 2022 JurisdictionWe have entered into an Equity Distribution Agreement, or the Equity Distribution Agreement, with Piper Sandler & Co., or Piper Sandler, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Equity Distribution Agreement, we may offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $9,801,287 from time to time through Piper Sandler acting as our agent.